1981
DOI: 10.1001/archderm.117.4.247
|View full text |Cite
|
Sign up to set email alerts
|

Basal cell epithelioma arising in a linear epidermal nevus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
11
0

Year Published

1982
1982
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…However, epithelial tumors arising in the area of NONEEN have rarely been described in the literature. For BCC associated with non-organoid epidermal nevi, approximately 10 cases have been reported so far [6,7,8,9]. Furthermore, the development of squamous cell carcinomas was occasionally observed in epidermal nevi [10].…”
Section: Discussionmentioning
confidence: 99%
“…However, epithelial tumors arising in the area of NONEEN have rarely been described in the literature. For BCC associated with non-organoid epidermal nevi, approximately 10 cases have been reported so far [6,7,8,9]. Furthermore, the development of squamous cell carcinomas was occasionally observed in epidermal nevi [10].…”
Section: Discussionmentioning
confidence: 99%
“…There are about 13 reports of squamous cell carcinoma [2, 3] and isolated cases of Bowen's disease [4], keratoacanthoma [5], apocrine multifocal papillary adenoma [6] and malignant eccrine poroma [7] arising from verrucous epidermal nevi. There are very few reports describing BCC appearing on verrucous epidermal nevi [8, 9, 10, 11, 12, 13, 14]. …”
Section: Discussionmentioning
confidence: 99%
“…Basal cell carcinoma (BCC),[17] keratoacanthoma,[1819] and squamous cell carcinoma (SCC)[20] have been reported to develop in cutaneous linear epidermal nevus, but this appears to be an extremely rare event. Ichikawa et al [21] reported 16 cases of linear epidermal nevi associated with malignant change (BCC, SCC, Bowen's disease, verrucous carcinoma, adnexal carcinoma).…”
Section: Discussionmentioning
confidence: 99%